» Authors » Shui-Ping Gao

Shui-Ping Gao

Explore the profile of Shui-Ping Gao including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 326
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang P, Wu J, Luo J, Li K, Wang F, Huang W, et al.
Aging (Albany NY) . 2019 Oct; 11(19):8204-8216. PMID: 31581131
Recently, an increasing number of studies have reported that dysregulation of long noncoding RNAs (lncRNAs) plays an important role in cancer initiation and progression, including in epithelial ovarian carcinoma (EOC)....
2.
Chen M, Sun H, Li L, Zhao Y, Yang L, Gao S, et al.
Oncol Lett . 2018 May; 15(6):8582-8588. PMID: 29805593
Cancer metastasis and relapse are the primary cause of mortality for patients with breast cancer. The present study performed quantitative proteomic analysis on the differentially expressed proteins between highly metastatic...
3.
Zhao Y, Sun H, Chen M, Gao S, Li L, Jiang H, et al.
Cancer Med . 2018 May; 7(6):2307-2318. PMID: 29722170
The objective of this study was to investigate the clinicopathological characteristics and survival outcomes of Paget disease (PD), Paget disease concomitant infiltrating duct carcinoma (PD-IDC), and Paget disease concomitant intraductal...
4.
Sun H, Zhao Y, Gao S, Li L, Fu W, Jiang H, et al.
Oncotarget . 2017 Oct; 8(41):69680-69690. PMID: 29050233
To investigate the clinicopathological characteristics and survival outcomes of breast cancer in the male population, 8,607 cases of patients were identified in the Surveillance, Epidemiology, and End Results (SEER) database,...
5.
Chen M, Sun H, Zhao Y, Fu W, Yang L, Gao S, et al.
Sci Rep . 2017 Aug; 7(1):9254. PMID: 28835702
To investigate the effects of age at diagnosis on metastatic breast cancer and patients' prognosis, we collected patient data from the Surveillance, Epidemiology, and End Results (SEER) database. We finally...
6.
Gao S, Sun H, Li L, Fu W, Jin W
Am J Cancer Res . 2017 Jul; 7(7):1554-1565. PMID: 28744404
UHRF1 is an epigenetic regulator and perform pivotal functions in cell tumorigenesis. We found UHRF1 is increased in breast cancer and patients with high UHRF1 levels have poorer prognoses than...
7.
Gao S, Sun H, Fu W, Li L, Zhao Y, Chen M, et al.
Future Oncol . 2017 Jun; 13(19):1711-1719. PMID: 28592145
Background: Cytochrome c oxidase subunit VB (COX5B), a subunit of mammalian COX, takes roles in COX assembling and functions. Online database predicts high COX5B transcription may be associated with worse...
8.
Jiang H, Sun H, Gao S, Li L, Huang S, Hu X, et al.
Cancer Res . 2015 Dec; 76(4):952-64. PMID: 26676758
Triple-negative breast cancer (TNBC) is a highly aggressive tumor subtype lacking effective prognostic indicators or therapeutic targets. Mitochondrial function is dysregulated frequently in cancer cells to allow for adaptation to...
9.
Li L, Sun H, Liu X, Gao S, Jiang H, Hu X, et al.
PLoS One . 2015 Dec; 10(12):e0144441. PMID: 26641458
Despite advances in basic and clinical research, metastasis remains the leading cause of death in breast cancer patients. Genetic abnormalities in mitochondria, including mutations affecting complex I and oxidative phosphorylation,...
10.
Gao S, Sun H, Jiang H, Li L, Hu X, Xu X, et al.
Oncotarget . 2015 Oct; 6(41):43363-74. PMID: 26506233
COX5B, a peripheral subunit of the cytochrome c oxidase complex, has previously been reported to maintain the stability of this complex. However, its functions and mechanisms involved in breast cancer...